Can a wearable glucose monitor keep hospital patients safer?

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with Type 1 and Type 2 diabetes. * Subjects 18 years of age or older with diabetes. * Subjects willing to avoid using high dose acetaminophen (defined as greater than 4 gm per day) * Subjects with expected hospital length-of-stay of 2 or more days beyond the time of enrollment. * Subjects willing to wear CGM device. Exclusion Criteria: * Female subjects who are pregnant or lactating at the time of enrollment into the study. Females with childbearing potential will be queried about the possibility of pregnancy and a serum pregnancy test will be performed. * Subjects with greater than 4gm use of Tylenol/24 hr. * Surgical patients or patients with pre-planned surgery or procedure in the next 48 hours. * Subjects with acute illness admitted to the ICU or expected to require admission to the ICU. * Patients who may potentially require IV insulin. * Patients with skin lesions, severe psoriasis, burns, tattoos, scarring, redness, infection or edema at the application sites that could interfere with device placement or the accuracy of interstitial glucose measurements. * Patient with a known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin. * Patients who have had organ transplant. * Patients with any severe medical conditions such as end-stage renal disease on dialysis, status post renal transplantation, end-stage liver disease with diffuse anasarca, heart failure on inotropic support, Ejection Fraction (EF) \< 15 % or severe sepsis. * Any condition for which, in the opinion of the investigators, it would not be in the best interest of the participant. * Legally protected subjects (under judicial protection, guardianship, or supervision), persons deprived of their liberty, mental or language barriers rendering the subject unable to understand the nature, scope and possible consequences of the study. * Subjects with active substance abuse. * Subjects with infaust prognosis.